When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Hidradenitis suppurativa

ბოლო მიმოხილვა: 11 Feb 2026
ბოლო განახლება: 07 Jan 2022

შეჯამება

განსაზღვრება

ანამნეზი და გასინჯვა

ძირითადი დიაგნოსტიკური ფაქტორები

  • at-risk demographic
  • history of acne vulgaris
  • recurrent disease
  • poor response to previous antibiotic therapy
  • open comedones in intertriginous (axilla, groin, perineum, or inframammary) areas
  • nodules or abscess
  • symmetrical distribution
  • sinus tracts with scarring
სრული ტექსტი

სხვა დიაგნოსტიკური ფაქტორები

  • premenstrual flare
სრული ტექსტი

რისკფაქტორები

  • obesity
  • female sex
  • smoking
  • positive family history
  • African-American
სრული ტექსტი

დიაგნოსტიკური კვლევები

Tests to consider

  • bacterial culture
  • skin biopsy
Full details

Treatment algorithm

ACUTE

acute abscess

ONGOING

mild (Hurley stage I)

moderate (Hurley stage II)

severe (Hurley stage III)

Contributors

Authors

David Cassarino, MD, PhD

Consultant Dermatopathologist

Southern California Permanente Medical Group

Los Angeles Medical Center

Los Angeles

CA

Disclosures

DC declares that he has no competing interests.

Acknowledgements

Dr David Cassarino would like to gratefully acknowledge Dr Robert A. Lee, the previous contributor to this topic.

RAL declares that he has no competing interests.

Peer reviewers

David R. Adams, MD, PharmD

Associate Professor of Dermatology

Penn State Hershey Medical Center

Hershey

PA

Disclosures

DRA declares that he has no competing interests.

Ravi Ubriani, MD, FAAD

Assistant Professor of Clinical Dermatology

Columbia University

New York

NY

利益声明

RU declares that he has no competing interests.

Andrew Carmichael, MB, BS

Consultant Dermatologist

James Cook University Hospital

Middlesbrough

UK

利益声明

AC declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Kim WB, Sibbald RG, Hu H, et al. Clinical features and patient outcomes of hidradenitis suppurativa: a cross-sectional retrospective study. J Cutan Med Surg. 2016;20:52-57.全文  摘要

Martorell A, García-Martínez FJ, Jiménez-Gallo D, et al. An update on hidradenitis suppurativa (part I): epidemiology, clinical aspects, and definition of disease severity. Actas Dermosifiliogr. 2015;106:703-715.全文  摘要

Sabat R, Jemec GBE, Matusiak Ł, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020 Mar 12;6(1):18. 摘要

Martorell A, García FJ, Jiménez-Gallo D, et al. Update on hidradenitis suppurativa (part II): treatment. Actas Dermosifiliogr. 2015;106:716-724.全文  摘要

Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375:422-34.全文  摘要

Ingram JR, Woo PN, Chua SL, et al. Interventions for hidradenitis suppurativa. Cochrane Database Syst Rev. 2015;(10):CD010081.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Hidradenitis suppurativa images
  • 鉴别诊断

    • Acne vulgaris
    • Crohn disease
    • Inverse psoriasis
    更多 鉴别诊断
  • 指南

    • Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group
    • Guidelines for the management of hidradenitis suppurativa (acne inversa)
    更多 指南
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明